{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:01:48Z","timestamp":1788498108474,"version":"build-2803163510"},"reference-count":55,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100006597","name":"Florida State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006597","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007472","name":"University of Kentucky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007472","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH2110504"],"award-info":[{"award-number":["W81XWH2110504"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Develop Med Child Neuro"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To characterize age\u2010specific patterns of attention\u2010deficit\/hyperactivity disorder (ADHD) symptoms and identify symptom profiles, as well as their associations with demographic and disease\u2010specific factors, in a large international sample of children with neurofibromatosis type 1 (NF1).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>Observational data from 904 assessments in 656 children with NF1 (age mean [SD] 9\u2009years 6\u2009months [3\u2009years 11\u2009months]; range 3\u201318\u2009years; 43.4% female) across eight institutions were pooled. With a cross\u2010sectional design, age\u2010varying ADHD symptom patterns were examined using time\u2010varying effect modeling; latent profile analysis was used to classify symptom profiles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Across ages 3 to 17\u2009years, children with NF1 showed elevated inattention and hyperactivity\/impulsivity relative to the normative mean, with inverted U\u2010shaped age patterns peaking around age 10\u2009years. Four ADHD profiles emerged: typical range (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0416; 46.0%); severe combined (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0199; 22.0%); mild combined (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0181; 20.0%); and predominantly inattentive (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a0108; 12.0%). Greater symptom severity was associated with female sex and lower parental education.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation<\/jats:title>\n                    <jats:p>ADHD symptoms in children with NF1 were elevated across ages, with the greatest symptom burden in middle childhood, alongside substantial heterogeneity in symptom presentation. These findings underscore the need for early recognition, ongoing monitoring, and individualized interventions to mitigate long\u2010term academic, social, and functional impacts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dmcn.70423","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:50:34Z","timestamp":1785390634000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Attention\u2010deficit\/hyperactivity disorder in neurofibromatosis type 1"],"prefix":"10.1111","author":[{"given":"Yang","family":"Hou","sequence":"first","affiliation":[{"name":"Department of Behavioral Sciences and Social Medicine Florida State University  Tallahassee FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxiu","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Behavioral Sciences and Social Medicine Florida State University  Tallahassee FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Behavioral Sciences and Social Medicine Florida State University  Tallahassee FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela L.","family":"Wolters","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Branch Center for Cancer Research, National Cancer Institute, National Institutes of Health  Bethesda MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0932-1519","authenticated-orcid":false,"given":"Bonita P.","family":"Klein\u2010Tasman","sequence":"additional","affiliation":[{"name":"Department of Psychological and Brain Sciences University of Wisconsin\u2013Milwaukee  Milwaukee WI USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9637-2164","authenticated-orcid":false,"given":"Karin S.","family":"Walsh","sequence":"additional","affiliation":[{"name":"Children's National Hospital  Washington D.C USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie A.","family":"Pride","sequence":"additional","affiliation":[{"name":"The Children's Hospital at Westmead  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4472-4583","authenticated-orcid":false,"given":"Shruti","family":"Garg","sequence":"additional","affiliation":[{"name":"University of Manchester &amp; Manchester University Foundation NHS Trust  Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0461-1098","authenticated-orcid":false,"given":"Stephanie M.","family":"Morris","sequence":"additional","affiliation":[{"name":"Center for Autism Services, Science, and Innovation, Kennedy Krieger Institute  Baltimore MD USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafit","family":"Gilboa","sequence":"additional","affiliation":[{"name":"School of Occupational Therapy Hebrew University of Jerusalem  Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9565-3845","authenticated-orcid":false,"given":"Jonathan M.","family":"Payne","sequence":"additional","affiliation":[{"name":"Murdoch Children's Research Institute  Parkville Victoria Australia"},{"name":"Department of Pediatrics University of Melbourne  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.4","article-title":"Neurofibromatosis type 1","volume":"3","author":"Gutmann DH","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"e_1_2_9_3_1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/dmcn.14489","article-title":"Predictors of cognitive development in children with neurofibromatosis type 1 and plexiform neurofibromas","volume":"62","author":"Hou Y","year":"2020","journal-title":"Dev Med Child Neurol"},{"key":"e_1_2_9_4_1","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.3390\/cancers14235956","article-title":"Demographic and disease\u2010related predictors of socioemotional development in children with neurofibromatosis type 1 and plexiform neurofibromas: an exploratory study","volume":"14","author":"Hou Y","year":"2022","journal-title":"Cancers"},{"key":"e_1_2_9_5_1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jaac.2024.09.011","article-title":"Systematic review and meta\u2010analysis: attention deficit\/hyperactivity disorder symptoms in children with neurofibromatosis type 1","volume":"64","author":"Hou Y","year":"2025","journal-title":"Am Acad Child Adolesc Psychiatry"},{"key":"e_1_2_9_6_1","article-title":"Academic achievement of children and adolescents with neurofibromatosis type 1: A systematic review and meta\u2010analysis","author":"Yu L","year":"2025","journal-title":"Neuropsychology Review"},{"key":"e_1_2_9_7_1","article-title":"Visuospatial and visuomotor abilities of individuals with neurofibromatosis type 1: A systematic review and meta\u2010analysis","author":"Yu L","year":"2025","journal-title":"Neuropsychology Review"},{"key":"e_1_2_9_8_1","first-page":"14","article-title":"Internalizing and externalizing symptoms in individuals with neurofibromatosis type 1: A systematic review and meta\u2010analysis","author":"Liu D","year":"2025","journal-title":"Systematic Reviews"},{"key":"e_1_2_9_9_1","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/jamapsychiatry.2016.2600","article-title":"Disease burden and symptom structure of autism in neurofibromatosis type 1: A study of the International NF1\u2010ASD Consortium Team (INFACT)","volume":"73","author":"Morris SM","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"e_1_2_9_10_1","article-title":"Attention\u2010deficit\/hyperactivity disorder","author":"Faraone SV","year":"2024","journal-title":"Nature Reviews Disease Primers"},{"key":"e_1_2_9_11_1","article-title":"Longitudinal association between executive function and academic achievement in children with neurofibromatosis type 1 and plexiform neurofibromas","volume":"1","author":"Hou Y","year":"2023","journal-title":"J. Int. Neuropsychol. Soc"},{"key":"e_1_2_9_12_1","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1080\/87565641.2012.695831","article-title":"The impact of ADHD on the cognitive and academic functioning of children with NF1","volume":"37","author":"Pride NA","year":"2012","journal-title":"Dev. Neuropsychol."},{"key":"e_1_2_9_13_1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/dmcn.14517","article-title":"Social skills and autism spectrum disorder symptoms in children with neurofibromatosis type 1: Evidence for clinical trial outcomes","volume":"62","author":"Payne JM","year":"2020","journal-title":"Dev Med Child Neurol"},{"key":"e_1_2_9_14_1","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1177\/1087054719894384","article-title":"Cognition, ADHD symptoms, and functional impairment in children and adolescents with neurofibromatosis type 1","volume":"25","author":"Payne JM","year":"2021","journal-title":"J. Atten. Disord."},{"key":"e_1_2_9_15_1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3390\/cancers18030529","article-title":"Age\u2010Specific ADHD and Internalizing\/Externalizing Comorbidity in Children with Neurofibromatosis Type 1: A Multi\u2010Site Study","volume":"18","author":"Liu D","year":"2026","journal-title":"Cancers"},{"key":"e_1_2_9_16_1","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1017\/S0033291721000349","article-title":"Developmental trajectories of ADHD symptoms in a large population\u2010representative longitudinal study","volume":"52","author":"Murray AL","year":"2022","journal-title":"Psychological Medicine"},{"key":"e_1_2_9_17_1","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/10870547211025612","article-title":"Exploring ADHD symptoms and associated impairment across development","volume":"26","author":"Niina A","year":"2022","journal-title":"Journal of Attention Disorders"},{"key":"e_1_2_9_18_1","first-page":"103","article-title":"Maelstrom research guidelines for rigorous retrospective data harmonization","volume":"46","author":"Fortier I","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"e_1_2_9_19_1","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/aje\/kww098","article-title":"Comparison of standardization methods for the harmonization of phenotype data: an application to cognitive measures","volume":"184","author":"Griffith LE","year":"2016","journal-title":"Am. J. Epidemiol."},{"key":"e_1_2_9_20_1","volume-title":"ADHD Rating Scale\u2014IV: Checklists, norms, and clinical interpretation","author":"DuPaul GJ","year":"1998"},{"key":"e_1_2_9_21_1","volume-title":"Conners' rating scales\u2010revised manual","author":"Conners CK","year":"1997"},{"key":"e_1_2_9_22_1","volume-title":"Conners third edition (Conners 3)","author":"Conners CK","year":"2008"},{"key":"e_1_2_9_23_1","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.ridd.2011.06.014","article-title":"Using a Virtual Classroom environment to describe the attention deficits profile of children with neurofibromatosis type 1","volume":"32","author":"Gilboa Y","year":"2011","journal-title":"Res Dev Disabil"},{"key":"e_1_2_9_24_1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/mpr.7","article-title":"ADHD rating scale IV: Psychometric properties from a multinational study as clinician\u2010administered instrument","volume":"14","author":"Zhang S","year":"2005","journal-title":"International Journal of Methods in Psychiatric Research"},{"key":"e_1_2_9_25_1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1037\/a0025814","article-title":"A time\u2010varying effect model for intensive longitudinal data","volume":"17","author":"Tan X","year":"2012","journal-title":"Psychol. Methods"},{"key":"e_1_2_9_26_1","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-067016","article-title":"Academic achievement in children with neurofibromatosis type 1","volume":"155","author":"Hou Y","year":"2025","journal-title":"PEDIATRICS"},{"key":"e_1_2_9_27_1","article-title":"Everyday executive functions in children with neurofibromatosis type 1: Data from nine institutions","author":"Zong X","year":"2026","journal-title":"Neuropsychology"},{"key":"e_1_2_9_28_1","article-title":"Age trends of internalizing and externalizing problems in children with neurofibromatosis type 1: a multicenter study","author":"Liu D","journal-title":"European Child & Adolescent Psychiatry"},{"key":"e_1_2_9_29_1","first-page":"729","article-title":"Package \u2018mgcv\u2019","volume":"1","author":"Wood S","year":"2015","journal-title":"R package version"},{"key":"e_1_2_9_30_1","volume-title":"R: A language and environment for statistical computing","author":"Team RC","year":"2025"},{"key":"e_1_2_9_31_1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/10705510701575396","article-title":"Deciding on the number of classes in latent class analysis and growth mixture modeling: A Monte Carlo simulation study","volume":"14","author":"Nylund KL","year":"2007","journal-title":"Structural equation modeling: A multidisciplinary Journal"},{"key":"e_1_2_9_32_1","volume-title":"Mplus User's Guide","author":"Muth\u00e9n L","year":"1998"},{"key":"e_1_2_9_33_1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/00273171.2016.1167008","article-title":"Modeling clustered data with very few clusters","volume":"51","author":"McNeish D","year":"2016","journal-title":"Multivariate behavioral research"},{"key":"e_1_2_9_34_1","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s13311-012-0135-8","article-title":"The prevalence of DSM\u2010IV attention\u2010deficit\/hyperactivity disorder: a meta\u2010analytic review","volume":"9","author":"Willcutt EG","year":"2012","journal-title":"Neurotherapeutics"},{"key":"e_1_2_9_35_1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1375\/twin.9.4.507","article-title":"The latent class structure of ADHD is stable across informants","volume":"9","author":"Althoff RR","year":"2006","journal-title":"Twin Research and Human Genetics"},{"key":"e_1_2_9_36_1","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S2215-0366(23)00184-0","article-title":"Conceptual clarity needed in ADHD diagnosis and treatment","volume":"10","author":"Gyngell C","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"e_1_2_9_37_1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/pcn.12393","article-title":"Functional consequences of attention\u2010deficit hyperactivity disorder on children and their families","volume":"70","author":"Usami M.","year":"2016","journal-title":"Psychiatry and clinical neurosciences"},{"key":"e_1_2_9_38_1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00787-014-0634-8","article-title":"Long\u2010term course of ADHD symptoms from childhood to early adulthood in a community sample","volume":"24","author":"Dopfner M","year":"2015","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"e_1_2_9_39_1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1146\/annurev-psych-113011-143750","article-title":"Executive Functions","volume":"64","author":"Diamond A.","year":"2013","journal-title":"Annual Review of Psychology"},{"key":"e_1_2_9_40_1","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0503224102","article-title":"The NF1 tumor suppressor critically regulates TSC2 and mTOR","volume":"102","author":"Johannessen CM","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_2_9_41_1","article-title":"Brain volumes in genetic syndromes associated with mTOR dysregulation: a systematic review and meta\u2010analysis","author":"Payne JM","year":"2024","journal-title":"Mol Psychiatry"},{"key":"e_1_2_9_42_1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10643-015-0757-7","article-title":"The transition to kindergarten: Predicting socio\u2010behavioral outcomes for children with and without disabilities","volume":"45","author":"Welchons LW","year":"2017","journal-title":"Early Childhood Education Journal"},{"key":"e_1_2_9_43_1","doi-asserted-by":"crossref","first-page":"19649","DOI":"10.1073\/pnas.0707741104","article-title":"Attention\u2010deficit\/hyperactivity disorder is characterized by a delay in cortical maturation","volume":"104","author":"Shaw P","year":"2007","journal-title":"Proceedings of the National Academy of Sciences \u2010 PNAS"},{"key":"e_1_2_9_44_1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaac.2020.07.891","article-title":"Systematic review: Educational accommodations for children and adolescents with attention\u2010deficit\/hyperactivity disorder","volume":"60","author":"Lovett BJ","year":"2021","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"key":"e_1_2_9_45_1","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-065787","article-title":"Treatments for ADHD in children and adolescents: a systematic review","volume":"153","author":"Peterson BS","year":"2024","journal-title":"PEDIATRICS"},{"key":"e_1_2_9_46_1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/21622965.2022.2093113","article-title":"A longitudinal investigation of parental ratings and performance metrics for executive functioning and symptom severity in clinically referred youth with ADHD","volume":"12","author":"Tallberg P","year":"2023","journal-title":"Appl. Neuropsychology Child"},{"key":"e_1_2_9_47_1","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1177\/1087054720923736","article-title":"Meta\u2010analysis of sex differences in ADHD symptoms and associated cognitive deficits","volume":"25","author":"Loyer Carbonneau M","year":"2021","journal-title":"Journal of attention disorders"},{"key":"e_1_2_9_48_1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S2215-0366(24)00010-5","article-title":"Why are females less likely to be diagnosed with ADHD in childhood than males?","volume":"11","author":"Martin J.","year":"2024","journal-title":"The Lancet Psychiatry"},{"key":"e_1_2_9_49_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2022.103205","article-title":"Gender\u2010based differences in prevalence and effects of ADHD in adults: A systematic review","volume":"75","author":"Faheem M","year":"2022","journal-title":"Asian journal of psychiatry"},{"key":"e_1_2_9_50_1","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s10578-015-0578-3","article-title":"The association between socioeconomic disadvantage and attention deficit\/hyperactivity disorder (ADHD): a systematic review","volume":"47","author":"Russell AE","year":"2016","journal-title":"Child Psychiatry & Human Development"},{"key":"e_1_2_9_51_1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jpsychires.2021.06.002","article-title":"Predictors of cognitive, behavioural and academic difficulties in NF1","volume":"140","author":"Geoffray M\u2010M","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"e_1_2_9_52_1","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1177\/0269215517709890","article-title":"The biopsychosocial model of illness: a model whose time has come","volume":"31","author":"Wade DT","year":"2017","journal-title":"Clin. Rehabil."},{"key":"e_1_2_9_53_1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1101\/gad.352629.125","article-title":"Cognition and behavior in neurofibromatosis Type 1: Report and perspective from the cognition and behavior in NF1 (CABIN) Task Force","volume":"39","author":"Gutmann DH","year":"2025","journal-title":"Genes Dev."},{"key":"e_1_2_9_54_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2025.106355","article-title":"Systematic review: Biopsychosocial factors related to attention\u2010deficit\/hyperactivity disorder in children\/adolescents with neurofibromatosis type 1","volume":"178","author":"Hou Y","year":"2025","journal-title":"Neuroscience & Biobehavioral Reviews"},{"key":"e_1_2_9_55_1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1469-8749.2002.tb00780.x","article-title":"Treatment of ADHD in neurofibromatosis type 1","volume":"44","author":"Mautner V\u2010F","year":"2002","journal-title":"Dev Med Child Neurol"},{"key":"e_1_2_9_56_1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13023-014-0142-4","article-title":"The effect of methylphenidate on neurofibromatosis type 1: A randomised, double\u2010blind, placebo\u2010controlled, crossover trial","volume":"9","author":"Lion\u2010Fran\u00e7ois L","year":"2014","journal-title":"Orphanet J Rare Dis"}],"container-title":["Developmental Medicine &amp; Child Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dmcn.70423","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/dmcn.70423","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dmcn.70423","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:50:43Z","timestamp":1785390643000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dmcn.70423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":55,"alternative-id":["10.1111\/dmcn.70423"],"URL":"https:\/\/doi.org\/10.1111\/dmcn.70423","archive":["Portico"],"relation":{},"ISSN":["0012-1622","1469-8749"],"issn-type":[{"value":"0012-1622","type":"print"},{"value":"1469-8749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"2025-11-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"dmcn.70423"}}